Report says 20% of global cancer deaths could be avoided
A new study by the Bloomberg New Economy International Cancer Coalition says at least 20% of global cancer deaths could be avoided each year.
Stay updated with breaking news from Project Orbis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study by the Bloomberg New Economy International Cancer Coalition says at least 20% of global cancer deaths could be avoided each year.
/PRNewswire/ -- A new study by members of the Bloomberg New Economy International Cancer Coalition (the Coalition) says that at least 1.5 million deaths...
Around 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs.
The immune checkpoint inhibitor is already approved for use in lung cancer. Now it is also approved for use in combination with chemotherapy for locally advanced or metastatic biliary tract cancer.
Approval based on TOPAZ-1 Phase III trial results, which showed IMFINZI combination reduced risk of death by 20% vs. chemotherapy aloneWILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s IMFINZI® (durvalumab) has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tra...